BioCentury
ARTICLE | Company News

Advion, Quintiles deal

October 31, 2011 7:00 AM UTC

Quintiles will acquire fellow CRO Advion for an undisclosed amount in cash. Advion provides pharmacokinetic/pharmacodynamic testing, molecular screening, drug discovery and metabolism, biomarker disco...